Prevention Habits of Medical Doctors
ConditionPreventive Practice
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity Hospital, Clermont-Ferrand
About this trial
Preventive practices among physicians remain insufficiently studied, particularly in situations for which recommendations are limited or unavailable.
The PREVMED study aims to describe physicians' preventive practices and to investigate the sociodemographic, occupational, and lifestyle factors that may influence these practices.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Physician or medical resident volunteering to participate in the study.
Disqualifiers
Person not willing to participate in the study.
Trial population
Physicians and medical residents volunteering to participate in the PREVMED study. Participants are recruited through an online REDCap® questionnaire distributed through various channels, including social networks, mailing lists, and flyers containing a link to the questionnaire.
Trial design
Design model
Other
Time perspective
Cross-sectional
Treatments tested in this trial
PREVMED questionnaire
Other interventionAnonymous self-administered online questionnaire assessing physicians' preventive practices toward their patients, as well as sociodemographic, occupational, and lifestyle factors that may influence these practices.
Treatment groups
500 Participants
are divided into 1 treatment groupGroup A: Physicians and medical residents1 intervention
Trial outcomes
Primary outcomes
1
Assessment of patients' preventive health behaviors
Frequency of assessment of patients regarding physical activity, diet, tobacco consumption, alcohol consumption, cannabis consumption, and sun exposure. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent assessment.
Time frame
Baseline2
Oral preventive advice provided to patients
Frequency of oral advice provided to patients regarding physical activity, diet, tobacco consumption, alcohol consumption, cannabis consumption, and sun exposure. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent provision of oral advice.
Time frame
Baseline3
Written preventive advice or treatment prescribed to patients
Frequency of written advice or treatment prescribed to patients regarding physical activity, diet, tobacco consumption, alcohol consumption, cannabis consumption, and sun exposure. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent prescription of written advice or treatment.
Time frame
Baseline4
Referral to dedicated preventive consultations
Frequency of referral of patients to dedicated consultations for physical activity, diet, tobacco consumption, alcohol consumption, cannabis consumption, and sun exposure. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent referral.
Time frame
BaselineSecondary outcomes
1
Tobacco cessation treatments prescribed
Types of treatment prescribed for smoking cessation, including varenicline, nicotine patches, nicotine gum, bupropion, cytisine, and electronic cigarettes. Multiple responses are permitted.
Time frame
Baseline2
Screening blood tests prescribed
Types of screening blood tests prescribed, including complete blood count, lipid profile, blood glucose, renal function, viral serology, inflammatory markers, and other tests. Multiple responses are permitted.
Time frame
Baseline3
Frequency of screening blood tests
Frequency of prescription of screening blood tests, categorized as occasionally without a defined frequency, once a year, once every 2 years, every 3 to 5 years, more than 5 years apart, or more than 10 years apart.
Time frame
Baseline4
Criteria used for lung cancer screening
Criteria used to propose lung cancer screening, including smoking, occupational exposure, non-occupational exposure, family history of lung cancer, and other criteria. Multiple responses are permitted.
Time frame
BaselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov